Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Carcinosarcoma × pamiparib × Sarcoma × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1 Gynecologic 1

Conditions

Ovarian Neoplasms 1 Neuroectodermal Tumors 1 Nervous System Diseases 1 Neoplasms by Site 1 Neoplasms by Histologic Type 1 Neoplasms 1 Gliosarcoma 1 Glioblastoma 1 Central Nervous System Neoplasms 1 Carcinosarcoma 1 Brain Neoplasms 1 Astrocytoma 1

Interventions

Specimen Handling 8 Paclitaxel 6 Magnetic Resonance Spectroscopy 6 Nivolumab 5 Carboplatin 5 Biopsy 5 pembrolizumab 3 X-Rays 3 olaparib 2 ceralasertib 2 Taxes 2 trastuzumab deruxtecan 1 sargramostim 1 rucaparib 1 ribociclib 1 pelcitoclax 1 pazopanib 1 pamiparib 1 durvalumab 1 cobimetinib 1 cediranib 1 cabozantinib 1 belinostat 1 atezolizumab 1 apatinib 1 Trabectedin 1 Tissue Banks 1 TIC10 compound 1 Radiation 1 Phantoms, Imaging 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03933761 2021-08-10

PRECISE

Australia New Zealand Gynaecological Oncology Group

Phase 2 Withdrawn

GynecologicSarcoma

Carcinosarcoma, Ovarian Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡